Projects per year
Personal profile
External positions
National Institute of Mental Health
Oregon State University
University of Georgia
University of Washington
Washington State University
Fingerprint
Dive into the research topics where Thomas F. Murray is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 7 Finished
-
Analogs of the κ opioid receptor antagonist arodyn cyclized by ring-closing metathesis retain κ opioid receptor affinity, selectivity and κ opioid receptor antagonism
Fang, W. J., Murray, T. F. & Aldrich, J. V., Jul 2021, In: Medicinal Chemistry Research. 30, 7, p. 1397-1407 11 p.Research output: Contribution to journal › Article › peer-review
-
Conformational Constraint between Aromatic Residue Side Chains in the "message" Sequence of the Peptide Arodyn Using Ring Closing Metathesis Results in a Potent and Selective Kappa Opioid Receptor Antagonist
Gisemba, S. A., Ferracane, M. J., Murray, T. F. & Aldrich, J. V., Mar 25 2021, In: Journal of Medicinal Chemistry. 64, 6, p. 3153-3164 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor
Pierce, M. L., French, J. A. & Murray, T. F., Jun 2020, In: Biomedicine and Pharmacotherapy. 126, 110060.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Comparison of the pharmacologic profiles of arginine vasopressin and oxytocin analogs at marmoset, titi monkey, macaque, and human oxytocin receptors
Pierce, M. L., French, J. A. & Murray, T. F., May 2020, In: Biomedicine and Pharmacotherapy. 125, 109832.Research output: Contribution to journal › Article › peer-review
Open Access -
Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe- d -Phe]: A Mixed Opioid Receptor Agonist-Antagonist following Oral Administration
Ferracane, M. J., Brice-Tutt, A. C., Coleman, J. S., Simpson, G. G., Wilson, L. L., Eans, S. O., Stacy, H. M., Murray, T. F., McLaughlin, J. P. & Aldrich, J. V., May 6 2020, In: ACS Chemical Neuroscience. 11, 9, p. 1324-1336 13 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations